Pancreatic Cancer, Research and Clinical Trials

Meet the investigator: Michael B. Wallace, M.D.

By Nicole Ferrara • March 11, 2020
Estimated reading time: 1 minute

At Mayo Clinic Cancer Center, hundreds of researchers dedicate their professional lives to reducing the burden of cancer. Each one has a unique story. In this issue, Michael B. Wallace, M.D., a gastroenterologist at Mayo Clinic in Jacksonville, Florida, discusses his research on the early detection of pancreatic cancer.

Related

This article was originally published in Forefront, Mayo Clinic Cancer Center's online magazine, which ceased publication in December 2020.

cancer pancreatic cancer Pancreatic Cancer research Research and Clinical Trials
Subscribe
Request an Appointment
Find a Clinical Trial
Looking back on pancreatic cancer, 5 years later

Rita Krueger shares the lessons she has learned from her experience with pancreatic cancer diagnosis, treatment and survivorship.

Staging pancreatic cancer early with minimally invasive surgery shows positive results in patient prognosis, Mayo Clinic study finds

Performing a minor surgical procedure on patients newly diagnosed with pancreatic cancer helps to identify cancer spread early and determine the stage of cancer.

Predicting pancreatic cancer outcomes prior to surgery

Researchers demonstrated a way to predict survival outcomes for people with borderline resectable or locally advanced pancreatic cancer.